<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" nameag="viewport"/>
<title>Psychiatry E&amp;D   Mission 2.0, Lap 2   23 04 2025   2025 04 23</title>
<script src="https://cdn.tailwindcss.com"></script>
<script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
<script src="https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js"></script>
<style>
        /* Custom styles for enhanced aesthetics and responsiveness */
        .option-btn {
            transition: all 0.3s ease;
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
        }
        .option-btn:hover, .option-btn:active {
            transform: scale(1.02);
            box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
        }
        .option-btn.selected {
            background-color: #3b82f6;
            color: white;
        }
        .marked {
            background-color: #fef08a;
        }
        .progress-bar {
            transition: width 0.5s ease-in-out;
            background: linear-gradient(to right, #3b82f6, #22c55e);
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
            animation: pulse 2s infinite;
        }
        @keyframes pulse {
            0% { opacity: 1; }
            50% { opacity: 0.8; }
            100% { opacity: 1; }
        }
        .question-nav-btn, .result-nav-btn-grid {
            width: 40px;
            height: 40px;
            display: flex;
            align-items: center;
            justify-content: center;
            border-radius: 8px;
            font-size: 16px;
            touch-action: manipulation;
            transition: all 0.2s ease;
        }
        .question-nav-btn:hover, .question-nav-btn:active, .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
            transform: scale(1.05);
        }
        .answered {
            background-color: #22c55e;
            color: white;
        }
        .unanswered {
            background-color: #e5e7eb;
        }
        .marked-nav {
            border: 2px solid #fef08a;
        }
        .video-container, .audio-container {
            display: none;
            position: relative;
        }
        .video-container.active, .audio-container.active {
            display: block;
            animation: fadeIn 0.5s ease-in;
        }
        @keyframes fadeIn {
            from { opacity: 0; }
            to { opacity: 1; }
        }
        .section-transition {
            transition: opacity 0.3s ease;
        }
        .section-transition.hidden {
            opacity: 0;
            pointer-events: none;
        }
        .result-nav {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-top: 1rem;
        }
        .result-nav-btn {
            background-color: #4b5563;
            color: white;
            padding: 0.5rem 1rem;
            border-radius: 8px;
            transition: all 0.2s ease;
        }
        .result-nav-btn:hover, .result-nav-btn:active {
            background-color: #374151;
            transform: scale(1.05);
        }
        .result-nav-btn:disabled {
            background-color: #d1d5db;
            cursor: not-allowed;
        }
        .error-message {
            color: #dc2626;
            font-weight: bold;
            margin-top: 1rem;
        }
        /* Mobile-specific adjustments */
        @media (max-width: 640px) {
            .question-nav-btn, .result-nav-btn-grid {
                width: 38px;
                height: 38px;
                font-size: 14px;
            }
            .nav-panel, .results-nav-panel {
                width: 100%;
                max-width: 100%;
                overscroll-behavior: contain;
            }
            .option-btn {
                padding: 12px;
                font-size: 14px;
            }
            .header-text {
                font-size: 1.5rem;
            }
            .subheader-text {
                font-size: 0.875rem;
            }
            .button-group, .result-nav {
                flex-direction: column;
                gap: 0.5rem;
            }
            .result-nav-btn {
                width: 100%;
                text-align: center;
            }
        }
        /* Dark mode styles */
        .dark .bg-gray-100 {
            background-color: #1f2937;
        }
        .dark .bg-white {
            background-color: #374151;
        }
        .dark .text-gray-700 {
            color: #d1d5db;
        }
        .dark .text-gray-800 {
            color: #e5e7eb;
        }
        .dark .bg-gray-200 {
            background-color: #4b5563;
        }
        .dark .border {
            border-color: #4b5563;
        }
        .dark .bg-blue-500 {
            background-color: #2563eb;
        }
        .dark .hover\:bg-blue-600:hover {
            background-color: #1d4ed8;
        }
        .dark .bg-yellow-300 {
            background-color: #b45309;
            color: white;
        }
        .dark .hover\:bg-yellow-400:hover {
            background-color: #92400e;
        }
        .dark .bg-green-500 {
            background-color: #15803d;
        }
        .dark .hover\:bg-green-600:hover {
            background-color: #166534;
        }
        .dark .bg-gray-500 {
            background-color: #4b5563;
        }
        .dark .hover\:bg-gray-600:hover {
            background-color: #374151;
        }
        .dark .result-nav-btn, .dark .result-nav-btn-grid {
            background-color: #2563eb;
        }
        .dark .result-nav-btn:hover, .dark .result-nav-btn:active, .dark .result-nav-btn-grid:hover, .dark .result-nav-btn-grid:active {
            background-color: #1d4ed8;
        }
        .dark .result-nav-btn:disabled, .dark .result-nav-btn-grid:disabled {
            background-color: #4b5563;
        }
        .video-placeholder {
            width: 400px;
            height: 300px;
            background-color: #f0f0f0;
            display: flex;
            align-items: center;
            justify-content: center;
            cursor: pointer;
            margin-top: 10px;
            border-radius: 8px;
            border: 1px solid #ccc;
        }
        .play-icon {
            font-size: 40px;
            color: #007bff;
        }
        .video-loading {
            position: absolute;
            top: 50%;
            left: 50%;
            transform: translate(-50%, -50%);
            border: 4px solid #f3f3f3;
            border-top: 4px solid #3b82f6;
            border-radius: 50%;
            width: 40px;
            height: 40px;
            animation: spin 1s linear infinite;
        }
        @keyframes spin {
            0% { transform: translate(-50%, -50%) rotate(0deg); }
            100% { transform: translate(-50%, -50%) rotate(360deg); }
        }
    </style>

<script>
    // --- GEMINI AUTO-CAPTURE LISTENER ---
    // This function runs immediately after the quiz determines an answer is INCORRECT.
    function captureMistake(questionIndex, questionsData) {
        try {
            const item = questionsData[questionIndex];
            // Use the question text as a unique, stable identifier
            const uniqueId = 'srs_quiz_' + btoa(item.text.substring(0, 50)).replace(/=/g, ''); 

            // 1. Clean and simplify the explanation for storage
            let explanationText = item.explanation || item.correct_answer || "No explanation provided.";
            
            // Strip complex HTML (images, lists) and boilerplate text
            explanationText = explanationText.replace(/<img[^>]*>/g, "[IMAGE]").trim(); // Replace images with placeholder
            explanationText = explanationText.replace(/<p><strong>Ans\. [A-Z]\).*/i, "").trim(); // Remove the repeated Answer line
            explanationText = explanationText.replace(/<p><strong>Educational Objective:<\/strong>.*?<\/p>/gs, "").trim(); // Remove EO block
            explanationText = explanationText.replace(/@dams_new_robot/g, "");
            explanationText = explanationText.replace(/<\/?[^>]+(>|$)/g, " ").trim(); // Final strip of remaining tags

            // 2. Prepare card data
            const cardData = {
                text: item.text,
                answer: item.correct_answer,
                explanation: explanationText.substring(0, 500), // Keep explanations short
                nextReview: 0, // Due immediately
                reviews: 0,
                source: document.title.split('-')[0].trim() || 'Quiz'
            };

            // 3. Save to Local Storage (SRS Bank)
            localStorage.setItem(uniqueId, JSON.stringify(cardData));
            
            console.log(`ðŸ§  Captured Mistake #${questionIndex + 1} from ${document.title}`);

        } catch (e) {
            console.error("SRS Capture Failed:", e);
        }
    }
    // --- END GEMINI AUTO-CAPTURE LISTENER ---
</script>

</head>
<body class="bg-gray-100 font-sans transition-colors duration-300 min-h-screen overflow-y-auto">
<!-- Header Section -->
<header class="bg-blue-600 text-white p-4 shadow-lg">
<div class="container mx-auto">
<h1 class="text-2xl md:text-3xl font-bold header-text">Psychiatry E&amp;D   Mission 2.0, Lap 2   23 04 2025   2025 04 23</h1>
<p class="mt-2 text-sm md:text-base subheader-text">
                68 Questions | 272 Total Marks | 78 min Duration | ~68.82 sec/question
            </p>
<button class="mt-2 bg-gray-200 text-gray-800 px-3 py-1 rounded-lg hover:bg-gray-300 transition dark:bg-gray-600 dark:text-white" id="theme-toggle">
                Toggle Dark Mode
            </button>
</div>
</header>
<!-- Instructions Section -->
<section class="container mx-auto p-4 md:p-6 section-transition" id="instructions">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-xl font-semibold mb-4">Instructions</h2>
<ul class="list-disc list-inside space-y-2 text-gray-700">
<li>This test contains 68 multiple choice questions.</li>
<li>Each question has only one correct answer.</li>
<li>You will have 78 minutes to complete the test.</li>
<li>Click or tap on an option to select your answer.</li>
<li>Use the "Mark for Review" button to revisit questions.</li>
<li>Navigate using Previous/Next buttons or the Questions Navigation panel.</li>
<li>Click "Submit" to finish and view results.</li>
<li>The test will auto-submit when time runs out.</li>
</ul>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="start-test">Start Test</button>


</div>
<div class="error-message hidden" id="error-message"></div>
</div>
</section>
<!-- Quiz Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="quiz">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<!-- Progress Bar -->
<div class="w-full bg-gray-200 rounded-full h-3 mb-4">
<div class="progress-bar h-3 rounded-full" id="progress-bar" style="width: 0%"></div>
</div>
<!-- Question Header -->
<div class="flex flex-col md:flex-row justify-between items-center mb-4">
<h2 class="text-lg font-semibold" id="question-number">Question <span>1</span> of 68</h2>
<p class="text-lg font-semibold mt-2 md:mt-0" id="timer">Time Remaining: <span>00:00</span></p>
</div>
<!-- Question Content -->
<div class="mb-6" id="question-content">
<p class="text-gray-800 mb-4" id="question-text"></p>
<div class="flex flex-wrap gap-4 mb-4" id="question-images"></div>
<div class="space-y-3" id="options"></div>
</div>
<!-- Navigation Buttons -->
<div class="flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition w-full md:w-auto" disabled="" id="previous-btn">Previous</button>
<button class="bg-yellow-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-yellow-400 transition w-full md:w-auto" id="mark-review">Mark for Review</button>
<button class="bg-blue-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="next-btn">Next</button>
<button class="bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full md:w-auto" id="nav-toggle">Questions Navigation</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="submit-test">Submit Test</button>
</div>
</div>
</section>
<!-- Results Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="results">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-2xl font-semibold mb-4">Psychiatry E&amp;D   Mission 2.0, Lap 2   23 04 2025   2025 04 23 - Results</h2>
<div class="grid grid-cols-1 md:grid-cols-2 gap-4 mb-6">
<p><strong>Correct:</strong> <span id="correct-count">0</span></p>
<p><strong>Wrong:</strong> <span id="wrong-count">0</span></p>
<p><strong>Unanswered:</strong> <span id="unanswered-count">0</span></p>
<p><strong>Marked for Review:</strong> <span id="marked-count">0</span></p>
</div>
<h3 class="text-lg font-semibold mb-4" id="result-question-number">Question <span>1</span> of 68</h3>
<div class="space-y-6" id="results-content"></div>
<div class="result-nav">
<button aria-label="Previous question result" class="result-nav-btn" disabled="" id="prev-result">Previous</button>
<button aria-label="Toggle results navigation panel" class="result-nav-btn" id="results-nav-toggle">Results Navigation</button>
<button aria-label="Next question result" class="result-nav-btn" id="next-result">Next</button>
</div>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="take-again">Take Again</button>
<button class="bg-gray-500 text-white px-6 py-2 rounded-lg hover:bg-gray-600 transition" id="review-test">Review Test</button>
</div>
</div>
</section>
<!-- Exit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="exit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Leave Test?</h2>
<p class="text-gray-700 mb-4">Your progress will be lost if you leave this page. Are you sure you want to exit?</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="continue-test">No, Continue</button>
<button class="bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition" id="exit-test">Yes, Exit</button>
</div>
</div>
</div>
<!-- Submit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="submit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Confirm Submission</h2>
<p class="text-gray-700 mb-2">You have attempted <span id="attempted-count">0</span> of 68 questions.</p>
<p class="text-gray-700 mb-4"><span id="unattempted-count">0</span> questions are unattempted.</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="cancel-submit">Cancel</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-green-600 transition" id="confirm-submit">Submit Test</button>
</div>
</div>
</div>
<!-- Quiz Navigation Panel -->
<div class="fixed inset-y-0 right-0 nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="nav-panel">
<h2 class="text-lg font-semibold mb-4">Questions Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-nav">Close</button>
</div>
<!-- Results Navigation Panel -->
<div class="fixed inset-y-0 right-0 results-nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="results-nav-panel">
<h2 class="text-lg font-semibold mb-4">Results Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="results-nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="results-nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-results-nav">Close</button>
</div>
<!-- JavaScript Logic -->
<script>
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog("Attempting to parse questions_json");
            questions = [{"text": "A 34-year-old man is found unconscious with shallow breathing, pinpoint pupils, and a slow respiratory rate. His friend reports recent heroin use. What is the most appropriate immediate intervention?", "options": [{"label": "A", "text": "Flumazenil", "correct": false}, {"label": "B", "text": "Naloxone", "correct": true}, {"label": "C", "text": "Diazepam", "correct": false}, {"label": "D", "text": "Haloperidol", "correct": false}], "correct_answer": "B. Naloxone", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. B) Naloxone</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Opioid overdose triad : Respiratory depression Pinpoint pupils Decreased consciousness Naloxone is the first-line antidote , can be administered IV, IM, or intranasally . Repeat doses may be needed , especially with long-acting opioids. Monitor for re-sedation and withdrawal symptoms after reversal.</li><li>âž¤ Opioid overdose triad : Respiratory depression Pinpoint pupils Decreased consciousness</li><li>âž¤ Opioid overdose triad</li><li>âž¤ Respiratory depression Pinpoint pupils Decreased consciousness</li><li>âž¤ Respiratory depression</li><li>âž¤ Respiratory depression</li><li>âž¤ Pinpoint pupils</li><li>âž¤ Pinpoint pupils</li><li>âž¤ Decreased consciousness</li><li>âž¤ Decreased consciousness</li><li>âž¤ Naloxone is the first-line antidote , can be administered IV, IM, or intranasally .</li><li>âž¤ Naloxone</li><li>âž¤ first-line antidote</li><li>âž¤ IV, IM, or intranasally</li><li>âž¤ Repeat doses may be needed , especially with long-acting opioids.</li><li>âž¤ Repeat doses may be needed</li><li>âž¤ Monitor for re-sedation and withdrawal symptoms after reversal.</li><li>âž¤ re-sedation</li><li>âž¤ withdrawal symptoms</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 35-year-old man on haloperidol presents with high-grade fever, muscle rigidity, fluctuating blood pressure, confusion, and elevated creatine kinase levels. What is the most appropriate next step in his management?", "options": [{"label": "A", "text": "Increase haloperidol dose", "correct": false}, {"label": "B", "text": "Add propranolol", "correct": false}, {"label": "C", "text": "Stop antipsychotic and start IV fluids", "correct": true}, {"label": "D", "text": "Continue antipsychotic and add benzodiazepine", "correct": false}], "correct_answer": "C. Stop antipsychotic and start IV fluids", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. C) Stop antipsychotic and start IV fluids</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Neuroleptic Malignant Syndrome (NMS) is a medical emergency caused by dopamine receptor blockade , often due to typical antipsychotics . Key features : Hyperthermia Lead-pipe rigidity Autonomic instability Elevated CK and leukocytosis First step : Stop antipsychotic + supportive care (IV fluids, cooling) Drug of choice in moderate-to-severe NMS: Dantrolene (a skeletal muscle relaxant) Alternatives: Bromocriptine , Amantadine , or Benzodiazepines</li><li>âž¤ Neuroleptic Malignant Syndrome (NMS) is a medical emergency caused by dopamine receptor blockade , often due to typical antipsychotics .</li><li>âž¤ Neuroleptic Malignant Syndrome (NMS)</li><li>âž¤ dopamine receptor blockade</li><li>âž¤ typical antipsychotics</li><li>âž¤ Key features : Hyperthermia Lead-pipe rigidity Autonomic instability Elevated CK and leukocytosis</li><li>âž¤ Key features</li><li>âž¤ Hyperthermia Lead-pipe rigidity Autonomic instability Elevated CK and leukocytosis</li><li>âž¤ Hyperthermia</li><li>âž¤ Hyperthermia</li><li>âž¤ Lead-pipe rigidity</li><li>âž¤ Lead-pipe rigidity</li><li>âž¤ Autonomic instability</li><li>âž¤ Autonomic instability</li><li>âž¤ Elevated CK and leukocytosis</li><li>âž¤ Elevated CK and leukocytosis</li><li>âž¤ First step : Stop antipsychotic + supportive care (IV fluids, cooling)</li><li>âž¤ First step</li><li>âž¤ Stop antipsychotic + supportive care (IV fluids, cooling)</li><li>âž¤ Drug of choice in moderate-to-severe NMS: Dantrolene (a skeletal muscle relaxant) Alternatives: Bromocriptine , Amantadine , or Benzodiazepines</li><li>âž¤ Drug of choice</li><li>âž¤ Dantrolene</li><li>âž¤ Alternatives: Bromocriptine , Amantadine , or Benzodiazepines</li><li>âž¤ Alternatives: Bromocriptine , Amantadine , or Benzodiazepines</li><li>âž¤ Bromocriptine</li><li>âž¤ Amantadine</li><li>âž¤ Benzodiazepines</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 45-year-old male patient with schizophrenia, who had inadequate response to multiple antipsychotics, including haloperidol and olanzapine, was started on drug A. After starting the treatment, his psychotic symptoms improved significantly; however, he developed tremors, rigidity, and bradykinesia. These symptoms are suggestive of parkinsonism. Which drug is most likely to be drug A?", "options": [{"label": "A", "text": "Clozapine", "correct": false}, {"label": "B", "text": "Olanzapine", "correct": false}, {"label": "C", "text": "Risperidone", "correct": true}, {"label": "D", "text": "Quetiapine", "correct": false}], "correct_answer": "C. Risperidone", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. C) Risperidone</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Among second-generation antipsychotics, risperidone is most associated with extrapyramidal side effects , especially at higher doses, due to potent D2 antagonism . In contrast, clozapine and quetiapine have a lower risk of causing parkinsonism and are preferred in patients prone to motor side effects.</li><li>âž¤ Among second-generation antipsychotics, risperidone is most associated with extrapyramidal side effects , especially at higher doses, due to potent D2 antagonism .</li><li>âž¤ risperidone</li><li>âž¤ extrapyramidal side effects</li><li>âž¤ D2 antagonism</li><li>âž¤ In contrast, clozapine and quetiapine have a lower risk of causing parkinsonism and are preferred in patients prone to motor side effects.</li><li>âž¤ clozapine and quetiapine</li><li>âž¤ lower risk</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 23-year-old man diagnosed with schizophrenia shows reduced facial expression, minimal speech, lack of motivation, and social withdrawal. Which of the following is classified as a negative symptom?", "options": [{"label": "A", "text": "Delusions", "correct": false}, {"label": "B", "text": "Auditory hallucinations", "correct": false}, {"label": "C", "text": "Alogia", "correct": true}, {"label": "D", "text": "Thought broadcasting", "correct": false}], "correct_answer": "C. Alogia", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. C) Alogia</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Negative symptoms of schizophrenia : Alogia (poverty of speech) Avolition (lack of motivation) Anhedonia (loss of pleasure) Asociality (social withdrawal) Blunted affect Pathophysiology : Involves hypofunction of the mesocortical dopamine pathway , especially projecting from the ventral tegmental area (VTA) to the prefrontal cortex . This contrasts with hyperdopaminergic activity in the mesolimbic pathway , which is associated with positive symptoms . Clinical relevance : Negative symptoms are less responsive to antipsychotics , especially first-generation agents. Associated with greater long-term disability and poorer social/occupational functioning .</li><li>âž¤ Negative symptoms of schizophrenia : Alogia (poverty of speech) Avolition (lack of motivation) Anhedonia (loss of pleasure) Asociality (social withdrawal) Blunted affect</li><li>âž¤ Negative symptoms of schizophrenia</li><li>âž¤ Alogia (poverty of speech) Avolition (lack of motivation) Anhedonia (loss of pleasure) Asociality (social withdrawal) Blunted affect</li><li>âž¤ Alogia (poverty of speech)</li><li>âž¤ Alogia</li><li>âž¤ Avolition (lack of motivation)</li><li>âž¤ Avolition</li><li>âž¤ Anhedonia (loss of pleasure)</li><li>âž¤ Anhedonia</li><li>âž¤ Asociality (social withdrawal)</li><li>âž¤ Asociality</li><li>âž¤ Blunted affect</li><li>âž¤ Blunted affect</li><li>âž¤ Pathophysiology : Involves hypofunction of the mesocortical dopamine pathway , especially projecting from the ventral tegmental area (VTA) to the prefrontal cortex . This contrasts with hyperdopaminergic activity in the mesolimbic pathway , which is associated with positive symptoms .</li><li>âž¤ Pathophysiology</li><li>âž¤ Involves hypofunction of the mesocortical dopamine pathway , especially projecting from the ventral tegmental area (VTA) to the prefrontal cortex . This contrasts with hyperdopaminergic activity in the mesolimbic pathway , which is associated with positive symptoms .</li><li>âž¤ Involves hypofunction of the mesocortical dopamine pathway , especially projecting from the ventral tegmental area (VTA) to the prefrontal cortex .</li><li>âž¤ hypofunction of the mesocortical dopamine pathway</li><li>âž¤ ventral tegmental area (VTA) to the prefrontal cortex</li><li>âž¤ This contrasts with hyperdopaminergic activity in the mesolimbic pathway , which is associated with positive symptoms .</li><li>âž¤ hyperdopaminergic activity in the mesolimbic pathway</li><li>âž¤ positive symptoms</li><li>âž¤ Clinical relevance : Negative symptoms are less responsive to antipsychotics , especially first-generation agents. Associated with greater long-term disability and poorer social/occupational functioning .</li><li>âž¤ Clinical relevance</li><li>âž¤ Negative symptoms are less responsive to antipsychotics , especially first-generation agents. Associated with greater long-term disability and poorer social/occupational functioning .</li><li>âž¤ Negative symptoms are less responsive to antipsychotics , especially first-generation agents.</li><li>âž¤ less responsive to antipsychotics</li><li>âž¤ Associated with greater long-term disability and poorer social/occupational functioning .</li><li>âž¤ greater long-term disability and poorer social/occupational functioning</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 28-year-old woman on risperidone develops amenorrhea and galactorrhea. Her serum prolactin is elevated. Which mechanism best explains this condition?", "options": [{"label": "A", "text": "Dopamine D2 receptor blockade in the tuberoinfundibular pathway", "correct": true}, {"label": "B", "text": "Serotonin 5-HT2A receptor blockade in the mesolimbic pathway", "correct": false}, {"label": "C", "text": "Dopamine D1 receptor stimulation in the nigrostriatal pathway", "correct": false}, {"label": "D", "text": "GABAergic inhibition in the hypothalamus", "correct": false}], "correct_answer": "A. Dopamine D2 receptor blockade in the tuberoinfundibular pathway", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. A) Dopamine D2 receptor blockade in the tuberoinfundibular pathway</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Antipsychotic-induced hyperprolactinemia is due to D2 receptor blockade in the tuberoinfundibular pathway . Dopamine normally inhibits prolactin release from the anterior pituitary. High-prolactin antipsychotics : Risperidone, Paliperidone, Amisulpride Low-prolactin antipsychotics : Aripiprazole (D2 partial agonist), Quetiapine</li><li>âž¤ Antipsychotic-induced hyperprolactinemia is due to D2 receptor blockade in the tuberoinfundibular pathway .</li><li>âž¤ Antipsychotic-induced hyperprolactinemia</li><li>âž¤ D2 receptor blockade in the tuberoinfundibular pathway</li><li>âž¤ Dopamine normally inhibits prolactin release from the anterior pituitary.</li><li>âž¤ inhibits prolactin release</li><li>âž¤ High-prolactin antipsychotics : Risperidone, Paliperidone, Amisulpride</li><li>âž¤ High-prolactin antipsychotics</li><li>âž¤ Risperidone, Paliperidone, Amisulpride</li><li>âž¤ Low-prolactin antipsychotics : Aripiprazole (D2 partial agonist), Quetiapine</li><li>âž¤ Low-prolactin antipsychotics</li><li>âž¤ Aripiprazole (D2 partial agonist), Quetiapine</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 25-year-old man presents with elevated mood, increased energy, pressured speech, grandiose ideas, and decreased need for sleep for the past 7 days. He is socially intrusive and has gone on a shopping spree. Which of the following best describes this clinical presentation?", "options": [{"label": "A", "text": "Schizoaffective disorder", "correct": false}, {"label": "B", "text": "Mania", "correct": true}, {"label": "C", "text": "Hypomania", "correct": false}, {"label": "D", "text": "Cyclothymia", "correct": false}], "correct_answer": "B. Mania", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. B) Mania</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Mania diagnostic criteria: Elevated or irritable mood â‰¥1 week (or any duration if hospitalization is needed) Plus 3 or more symptoms : inflated self-esteem, decreased need for sleep, talkativeness, flight of ideas, distractibility, increased goal-directed activity, risky behavior Marked impairment in functioning Distinguished from hypomania by severity and functional impairment Treated with mood stabilizers (lithium, valproate) and/or atypical antipsychotics</li><li>âž¤ Mania diagnostic criteria: Elevated or irritable mood â‰¥1 week (or any duration if hospitalization is needed) Plus 3 or more symptoms : inflated self-esteem, decreased need for sleep, talkativeness, flight of ideas, distractibility, increased goal-directed activity, risky behavior Marked impairment in functioning</li><li>âž¤ Mania</li><li>âž¤ Elevated or irritable mood â‰¥1 week (or any duration if hospitalization is needed) Plus 3 or more symptoms : inflated self-esteem, decreased need for sleep, talkativeness, flight of ideas, distractibility, increased goal-directed activity, risky behavior Marked impairment in functioning</li><li>âž¤ Elevated or irritable mood â‰¥1 week (or any duration if hospitalization is needed)</li><li>âž¤ â‰¥1 week</li><li>âž¤ Plus 3 or more symptoms : inflated self-esteem, decreased need for sleep, talkativeness, flight of ideas, distractibility, increased goal-directed activity, risky behavior</li><li>âž¤ 3 or more symptoms</li><li>âž¤ Marked impairment in functioning</li><li>âž¤ Marked impairment</li><li>âž¤ Distinguished from hypomania by severity and functional impairment</li><li>âž¤ Distinguished from hypomania</li><li>âž¤ severity and functional impairment</li><li>âž¤ Treated with mood stabilizers (lithium, valproate) and/or atypical antipsychotics</li><li>âž¤ mood stabilizers (lithium, valproate)</li><li>âž¤ atypical antipsychotics</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 42-year-old man with bipolar disorder stable on lithium therapy is started on a medication for hypertension. One week later, he presents with tremors, confusion, and nausea. His serum lithium level is elevated. Which of the following medications is most likely responsible?", "options": [{"label": "A", "text": "Amlodipine", "correct": false}, {"label": "B", "text": "Hydrochlorothiazide", "correct": true}, {"label": "C", "text": "Metoprolol", "correct": false}, {"label": "D", "text": "Paracetamol", "correct": false}], "correct_answer": "B. Hydrochlorothiazide", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. B) Hydrochlorothiazide</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Lithium is renally excreted and has a narrow therapeutic index . Drugs that increase lithium levels (â†‘ risk of toxicity): Thiazide diuretics (e.g., hydrochlorothiazide) NSAIDs ACE inhibitors / ARBs Signs of lithium toxicity : Tremor, confusion, GI upset, ataxia, seizures</li><li>âž¤ Lithium is renally excreted and has a narrow therapeutic index .</li><li>âž¤ Lithium</li><li>âž¤ narrow therapeutic index</li><li>âž¤ Drugs that increase lithium levels (â†‘ risk of toxicity): Thiazide diuretics (e.g., hydrochlorothiazide) NSAIDs ACE inhibitors / ARBs</li><li>âž¤ Drugs that increase lithium levels</li><li>âž¤ Thiazide diuretics (e.g., hydrochlorothiazide) NSAIDs ACE inhibitors / ARBs</li><li>âž¤ Thiazide diuretics (e.g., hydrochlorothiazide)</li><li>âž¤ Thiazide diuretics</li><li>âž¤ NSAIDs</li><li>âž¤ NSAIDs</li><li>âž¤ ACE inhibitors / ARBs</li><li>âž¤ ACE inhibitors / ARBs</li><li>âž¤ Signs of lithium toxicity : Tremor, confusion, GI upset, ataxia, seizures</li><li>âž¤ Signs of lithium toxicity</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "All of the following are true about somnambulism, except:", "options": [{"label": "A", "text": "It occurs during non-REM sleep", "correct": false}, {"label": "B", "text": "The individual usually has no memory of the episode", "correct": false}, {"label": "C", "text": "It commonly begins in adolescence and worsens with age", "correct": true}, {"label": "D", "text": "Episodes typically occur in the first third of the night", "correct": false}], "correct_answer": "C. It commonly begins in adolescence and worsens with age", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. C) It commonly begins in adolescence and worsens with age</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Somnambulism is a non-REM parasomnia that usually arises from stage N3 sleep . It commonly begins in childhood and usually resolves with age . Occurs in the first third of the night , with no memory of the episode. Management : Reassurance, safety measures; clonazepam may be used in frequent/severe cases.</li><li>âž¤ Somnambulism is a non-REM parasomnia that usually arises from stage N3 sleep .</li><li>âž¤ Somnambulism</li><li>âž¤ non-REM parasomnia</li><li>âž¤ stage N3 sleep</li><li>âž¤ It commonly begins in childhood and usually resolves with age .</li><li>âž¤ childhood</li><li>âž¤ resolves with age</li><li>âž¤ Occurs in the first third of the night , with no memory of the episode.</li><li>âž¤ first third of the night</li><li>âž¤ no memory</li><li>âž¤ Management : Reassurance, safety measures; clonazepam may be used in frequent/severe cases.</li><li>âž¤ Management</li><li>âž¤ clonazepam</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 5-year-old boy with delayed speech, poor eye contact, and repetitive hand-flapping movements is diagnosed with autism spectrum disorder. Which of the following genetic syndromes is most commonly associated with ASD?", "options": [{"label": "A", "text": "Fragile X syndrome", "correct": true}, {"label": "B", "text": "Turner syndrome", "correct": false}, {"label": "C", "text": "Klinefelter syndrome", "correct": false}, {"label": "D", "text": "Marfan syndrome", "correct": false}], "correct_answer": "A. Fragile X syndrome", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Syndromes associated with ASD : Fragile X syndrome â†’ most common genetic cause Tuberous sclerosis Rett syndrome (in females) Down syndrome (less frequent, but possible) Always consider genetic testing in children with ASD and intellectual disability. Fragile X presents with developmental delay , social anxiety , stereotypies , and physical dysmorphism .</li><li>âž¤ Syndromes associated with ASD : Fragile X syndrome â†’ most common genetic cause Tuberous sclerosis Rett syndrome (in females) Down syndrome (less frequent, but possible)</li><li>âž¤ Syndromes associated with ASD</li><li>âž¤ Fragile X syndrome â†’ most common genetic cause Tuberous sclerosis Rett syndrome (in females) Down syndrome (less frequent, but possible)</li><li>âž¤ Fragile X syndrome â†’ most common genetic cause</li><li>âž¤ Fragile X syndrome</li><li>âž¤ Tuberous sclerosis</li><li>âž¤ Tuberous sclerosis</li><li>âž¤ Rett syndrome (in females)</li><li>âž¤ Rett syndrome</li><li>âž¤ Down syndrome (less frequent, but possible)</li><li>âž¤ Down syndrome</li><li>âž¤ Always consider genetic testing in children with ASD and intellectual disability.</li><li>âž¤ genetic testing</li><li>âž¤ Fragile X presents with developmental delay , social anxiety , stereotypies , and physical dysmorphism .</li><li>âž¤ Fragile X</li><li>âž¤ developmental delay</li><li>âž¤ social anxiety</li><li>âž¤ stereotypies</li><li>âž¤ physical dysmorphism</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following statements about Attention-Deficit/Hyperactivity Disorder (ADHD) is not true?", "options": [{"label": "A", "text": "Symptoms must be present in at least two settings (e.g., home and school)", "correct": false}, {"label": "B", "text": "Methylphenidate is an effective non-stimulant treatment for ADHD", "correct": true}, {"label": "C", "text": "Symptoms often persist into adolescence and adulthood", "correct": false}, {"label": "D", "text": "Inattentive type ADHD may present without hyperactivity", "correct": false}], "correct_answer": "B. Methylphenidate is an effective non-stimulant treatment for ADHD", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. B) Methylphenidate is an effective non-stimulant treatment for ADHD</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ ADHD diagnostic criteria (DSM-5): Onset before age 12 6+ symptoms of inattention and/or hyperactivity for â‰¥6 months Impairment in â‰¥2 settings Stimulants (e.g., methylphenidate, amphetamines) are first-line treatments . Non-stimulants (e.g., atomoxetine, clonidine, guanfacine) are used when stimulants are ineffective, contraindicated, or not tolerated.</li><li>âž¤ ADHD diagnostic criteria (DSM-5): Onset before age 12 6+ symptoms of inattention and/or hyperactivity for â‰¥6 months Impairment in â‰¥2 settings</li><li>âž¤ ADHD diagnostic criteria</li><li>âž¤ Onset before age 12 6+ symptoms of inattention and/or hyperactivity for â‰¥6 months Impairment in â‰¥2 settings</li><li>âž¤ Onset before age 12</li><li>âž¤ before age 12</li><li>âž¤ 6+ symptoms of inattention and/or hyperactivity for â‰¥6 months</li><li>âž¤ 6+ symptoms</li><li>âž¤ Impairment in â‰¥2 settings</li><li>âž¤ â‰¥2 settings</li><li>âž¤ Stimulants (e.g., methylphenidate, amphetamines) are first-line treatments .</li><li>âž¤ Stimulants (e.g., methylphenidate, amphetamines)</li><li>âž¤ first-line treatments</li><li>âž¤ Non-stimulants (e.g., atomoxetine, clonidine, guanfacine) are used when stimulants are ineffective, contraindicated, or not tolerated.</li><li>âž¤ Non-stimulants</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "During the mental status examination, a patient is unable to perform seven serial subtractions. What does this test specifically assess?", "options": [{"label": "A", "text": "Memory", "correct": false}, {"label": "B", "text": "Abstract thinking", "correct": false}, {"label": "C", "text": "Concentration", "correct": true}, {"label": "D", "text": "Judgment", "correct": false}], "correct_answer": "C. Concentration", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. C) Concentration</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Serial 7s subtraction : Best for evaluating concentration , especially in cognitive screening tools like MMSE. Digit span forward : Assesses immediate memory & attention Digit span backward : Tests working memory</li><li>âž¤ Serial 7s subtraction : Best for evaluating concentration , especially in cognitive screening tools like MMSE.</li><li>âž¤ Serial 7s subtraction</li><li>âž¤ concentration</li><li>âž¤ Digit span forward : Assesses immediate memory & attention</li><li>âž¤ Digit span forward</li><li>âž¤ immediate memory & attention</li><li>âž¤ Digit span backward : Tests working memory</li><li>âž¤ Digit span backward</li><li>âž¤ working memory</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 40-year-old man with alcohol dependence is started on disulfiram. He is educated that consuming alcohol while on disulfiram will lead to unpleasant reactions such as flushing, nausea, and palpitations. Which learning mechanism best explains how disulfiram supports abstinence?", "options": [{"label": "A", "text": "Classical conditioning", "correct": false}, {"label": "B", "text": "Operant conditioning â€“ negative reinforcement", "correct": false}, {"label": "C", "text": "Operant conditioning â€“ positive punishment", "correct": true}, {"label": "D", "text": "Modeling", "correct": false}], "correct_answer": "C. Operant conditioning â€“ positive punishment", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. C) Operant conditioning â€“ positive punishment</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Disulfiram acts by creating aversive reactions when alcohol is consumed â†’ leads to behavioral deterrence . This is a form of operant conditioning â€“ positive punishment : Behavior (alcohol use) Followed by addition of aversive stimulus (disulfiram reaction) Leads to reduction in the behavior Not a craving reducerâ€”used as a deterrent , best in highly motivated patients under supervision.</li><li>âž¤ Disulfiram acts by creating aversive reactions when alcohol is consumed â†’ leads to behavioral deterrence .</li><li>âž¤ Disulfiram</li><li>âž¤ aversive reactions</li><li>âž¤ behavioral deterrence</li><li>âž¤ This is a form of operant conditioning â€“ positive punishment : Behavior (alcohol use) Followed by addition of aversive stimulus (disulfiram reaction) Leads to reduction in the behavior</li><li>âž¤ operant conditioning â€“ positive punishment</li><li>âž¤ Behavior (alcohol use) Followed by addition of aversive stimulus (disulfiram reaction) Leads to reduction in the behavior</li><li>âž¤ Behavior (alcohol use)</li><li>âž¤ Behavior</li><li>âž¤ Followed by addition of aversive stimulus (disulfiram reaction)</li><li>âž¤ addition of aversive stimulus</li><li>âž¤ Leads to reduction in the behavior</li><li>âž¤ reduction in the behavior</li><li>âž¤ Not a craving reducerâ€”used as a deterrent , best in highly motivated patients under supervision.</li><li>âž¤ deterrent</li><li>âž¤ highly motivated patients</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Consider the following statements regarding the management of schizophrenia: Statement 1: Clozapine is the first-line treatment for schizophrenia. Statement 2: Long-acting injectable antipsychotics are used to improve medication compliance. Statement 3: Extrapyramidal symptoms are more common with typical antipsychotics than atypical antipsychotics. Statement 4: Negative symptoms of schizophrenia respond better to clozapine than haloperidol. Which of the following is correct?", "options": [{"label": "A", "text": "Statements 2 and 3 are correct", "correct": false}, {"label": "B", "text": "Statements 1, 2, and 3 are correct", "correct": false}, {"label": "C", "text": "Statements 1, 3, and 4 are correct", "correct": false}, {"label": "D", "text": "Statements 2, 3, and 4 are correct", "correct": true}], "correct_answer": "D. Statements 2, 3, and 4 are correct", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. D) Statements 2, 3, and 4 are correct</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Clozapine is reserved for treatment-resistant cases . LAIs improve adherence in patients with poor compliance. Typical antipsychotics have a higher risk of EPS . Clozapine is superior for negative symptoms compared to haloperidol.</li><li>âž¤ Clozapine is reserved for treatment-resistant cases .</li><li>âž¤ Clozapine</li><li>âž¤ treatment-resistant cases</li><li>âž¤ LAIs improve adherence in patients with poor compliance.</li><li>âž¤ LAIs improve adherence</li><li>âž¤ Typical antipsychotics have a higher risk of EPS .</li><li>âž¤ Typical antipsychotics</li><li>âž¤ higher risk of EPS</li><li>âž¤ Clozapine is superior for negative symptoms compared to haloperidol.</li><li>âž¤ Clozapine is superior</li><li>âž¤ negative symptoms</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 35-year-old man is brought to the emergency department by police after creating a disturbance at his workplace. During evaluation, he appears agitated and insists that his wife is having multiple affairs, despite no evidence to support this belief. He describes following her, checking her phone and email repeatedly, and interpreting innocent interactions with male colleagues as proof of infidelity. What is the most likely diagnosis?", "options": [{"label": "A", "text": "Delusional misidentification syndrome", "correct": false}, {"label": "B", "text": "Othello syndrome", "correct": true}, {"label": "C", "text": "Erotomania", "correct": false}, {"label": "D", "text": "Folie Ã  deux", "correct": false}], "correct_answer": "B. Othello syndrome", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. B) Othello syndrome</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Othello syndrome (delusional jealousy):</li><li>âž¤ Othello syndrome</li><li>âž¤ A fixed, false belief that a partner is being unfaithful. Often involves checking behaviors, stalking, misinterpretation of benign interactions . Can arise in the context of delusional disorder , schizophrenia , or alcohol use .</li><li>âž¤ A fixed, false belief that a partner is being unfaithful.</li><li>âž¤ fixed, false belief</li><li>âž¤ Often involves checking behaviors, stalking, misinterpretation of benign interactions .</li><li>âž¤ checking behaviors, stalking, misinterpretation of benign interactions</li><li>âž¤ Can arise in the context of delusional disorder , schizophrenia , or alcohol use .</li><li>âž¤ delusional disorder</li><li>âž¤ schizophrenia</li><li>âž¤ alcohol use</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 22-year-old female patient diagnosed with bipolar disorder was started on aripiprazole 15 mg daily one week ago. Today she reports feeling extremely uncomfortable, describing a constant urge to pace and an inability to sit still during classes. On examination, she appears anxious and frequently shifts position while seated. Which medication side effect best explains these symptoms?", "options": [{"label": "A", "text": "Parkinsonism", "correct": false}, {"label": "B", "text": "Akathisia", "correct": true}, {"label": "C", "text": "Neuroleptic malignant syndrome", "correct": false}, {"label": "D", "text": "Dystonic reaction", "correct": false}], "correct_answer": "B. Akathisia", "question_images": [], "explanation_images": ["https://cerebellum-web-static.s3.amazonaws.com/media/public/image_jWtgmZH.png"], "explanation": "<p><strong>Ans. B) Akathisia</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 28-year-old graphic designer reports mood swings for the past two years. She describes periods of elevated energy and increased sociability lasting several days, alternating with times of low mood and fatigue. However, her symptoms have never met the full criteria for major depression or mania. Which of the following is the most likely diagnosis?", "options": [{"label": "A", "text": "Bipolar I disorder", "correct": false}, {"label": "B", "text": "Bipolar II disorder", "correct": false}, {"label": "C", "text": "Cyclothymia", "correct": true}, {"label": "D", "text": "Persistent depressive disorder", "correct": false}], "correct_answer": "C. Cyclothymia", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. C) Cyclothymia</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Cyclothymia is a chronic fluctuating mood disorder with subthreshold hypomanic and depressive symptoms lasting â‰¥2 years (â‰¥1 year in children/adolescents).</li><li>âž¤ Cyclothymia</li><li>âž¤ chronic fluctuating mood disorder</li><li>âž¤ subthreshold hypomanic and depressive symptoms</li><li>âž¤ â‰¥2 years</li><li>âž¤ Does not meet full criteria for major depressive, hypomanic, or manic episodes. Symptoms are present more than 50% of the time and no symptom-free period >2 months .</li><li>âž¤ Does not meet full criteria for major depressive, hypomanic, or manic episodes.</li><li>âž¤ Does not meet full criteria</li><li>âž¤ Symptoms are present more than 50% of the time and no symptom-free period >2 months .</li><li>âž¤ present more than 50% of the time</li><li>âž¤ no symptom-free period >2 months</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 27-year-old woman has an intense, irrational fear of flying and avoids all air travel, despite needing to fly for work. She experiences marked anxiety even thinking about planes. What is the therapy of choice for this condition?", "options": [{"label": "A", "text": "Cognitive restructuring", "correct": false}, {"label": "B", "text": "Therapeutic graded exposure", "correct": true}, {"label": "C", "text": "Supportive psychotherapy", "correct": false}, {"label": "D", "text": "Insight-oriented therapy", "correct": false}], "correct_answer": "B. Therapeutic graded exposure", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. B) Therapeutic graded exposure</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Specific phobia is treated most effectively with graded exposure therapy . Involves creating an anxiety hierarchy and exposing the person to feared stimuli in a controlled, step-wise manner . Works through extinction of conditioned fear responses and habituation . Medications are not first-line unless comorbidities are present.</li><li>âž¤ Specific phobia is treated most effectively with graded exposure therapy .</li><li>âž¤ Specific phobia</li><li>âž¤ graded exposure therapy</li><li>âž¤ Involves creating an anxiety hierarchy and exposing the person to feared stimuli in a controlled, step-wise manner .</li><li>âž¤ anxiety hierarchy</li><li>âž¤ controlled, step-wise manner</li><li>âž¤ Works through extinction of conditioned fear responses and habituation .</li><li>âž¤ extinction of conditioned fear responses</li><li>âž¤ habituation</li><li>âž¤ Medications are not first-line unless comorbidities are present.</li><li>âž¤ not first-line</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 30-year-old woman with temporal lobe epilepsy experiences a peculiar phenomenon at the beginning of her seizures. She reports that just before losing awareness, she repeatedly thinks of a specific mathematical equation that she cannot voluntarily suppress or control. This intrusive cognitive experience that occurs as part of her ictal state is best described as:", "options": [{"label": "A", "text": "Forced thinking", "correct": true}, {"label": "B", "text": "Obsession", "correct": false}, {"label": "C", "text": "Compulsion", "correct": false}, {"label": "D", "text": "Forced normalization", "correct": false}], "correct_answer": "A. Forced thinking", "question_images": [], "explanation_images": ["https://cerebellum-web-static.s3.amazonaws.com/media/public/image_iG7i8KM.png"], "explanation": "<p><strong>Ans. A) Forced thinking</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Ictal phenomena are symptoms that occur during epileptic seizures , often arising from temporal lobe epilepsy , and may mimic psychiatric disorders. Recognizing them is crucial for accurate diagnosis and treatment .</li><li>âž¤ Ictal phenomena</li><li>âž¤ during epileptic seizures</li><li>âž¤ temporal lobe epilepsy</li><li>âž¤ accurate diagnosis and treatment</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 45-year-old patient with a history of depression and insomnia is being evaluated for treatment. The provider prefers to use an antidepressant with sedative properties. Which of the following antidepressants are known for their sedative effects? Mirtazapine Trazodone Fluoxetine Venlafaxine Amitriptyline", "options": [{"label": "A", "text": "1, 2, 5", "correct": true}, {"label": "B", "text": "2, 4", "correct": false}, {"label": "C", "text": "3, 4, 5", "correct": false}, {"label": "D", "text": "1, 3", "correct": false}], "correct_answer": "A. 1, 2, 5", "question_images": [], "explanation_images": ["https://cerebellum-web-static.s3.amazonaws.com/media/public/image_xDKTCu6.png"], "explanation": "<p><strong>Ans. A) 1, 2, 5</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A patient with bipolar disorder is started on carbamazepine. Which of the following genetic factors increases the risk of Stevens-Johnson syndrome with this medication?", "options": [{"label": "A", "text": "HLA-B5701", "correct": false}, {"label": "B", "text": "HLA-B1502", "correct": true}, {"label": "C", "text": "HLA-DR4", "correct": false}, {"label": "D", "text": "HLA-A0201", "correct": false}], "correct_answer": "B. HLA-B1502", "question_images": [], "explanation_images": ["https://cerebellum-web-static.s3.amazonaws.com/media/public/image_FimbcCh.png"], "explanation": "<p><strong>Ans. B) HLA-B1502</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Certain HLA alleles are linked to severe drug hypersensitivity reactions :</li><li>âž¤ HLA alleles are linked to severe drug hypersensitivity reactions</li><li>âž¤ HLA-B*1502 testing helps prevent potentially fatal cutaneous reactions to carbamazepine , especially in patients of Asian ancestry .</li><li>âž¤ HLA-B*1502 testing</li><li>âž¤ potentially fatal cutaneous reactions</li><li>âž¤ carbamazepine</li><li>âž¤ Asian ancestry</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 34-year-old woman with recurrent depression reports improvement in mood on her current antidepressant but complains of reduced libido and difficulty achieving orgasm. Which of the following antidepressants is most likely responsible for this adverse effect?", "options": [{"label": "A", "text": "Bupropion", "correct": false}, {"label": "B", "text": "Mirtazapine", "correct": false}, {"label": "C", "text": "Paroxetine", "correct": true}, {"label": "D", "text": "Agomelatine", "correct": false}], "correct_answer": "C. Paroxetine", "question_images": [], "explanation_images": ["https://cerebellum-web-static.s3.amazonaws.com/media/public/image_fYxVNd8.png"], "explanation": "<p><strong>Ans. C) Paroxetine</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Selective Serotonin Reuptake Inhibitors (SSRIs) , including paroxetine , act by inhibiting the reuptake of serotonin (5-HT) in the synaptic cleft, enhancing serotonergic neurotransmission. They are widely used in depression, anxiety disorders, OCD, etc.</li><li>âž¤ Selective Serotonin Reuptake Inhibitors (SSRIs)</li><li>âž¤ paroxetine</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Match the following:", "options": [{"label": "A", "text": "A-4, B-1, C-3, D-2", "correct": false}, {"label": "B", "text": "A-4, B-3, C-1, D-2", "correct": true}, {"label": "C", "text": "A-2, B-1, C-3, D-4", "correct": false}, {"label": "D", "text": "A-2, B-3, C-4, D-1", "correct": false}], "correct_answer": "B. A-4, B-3, C-1, D-2", "question_images": ["https://cerebellum-web-static.s3.amazonaws.com/media/public/image_hrG8b4q.png"], "explanation_images": ["https://cerebellum-web-static.s3.amazonaws.com/media/public/image_UgZgahx.png"], "explanation": "<p><strong>Ans. B) A-4, B-3, C-1, D-2</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Eating disorders are classified based on eating behaviors and psychological factors:</li><li>âž¤ Eating disorders</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 30-year-old man with social anxiety disorder reports that he stopped his antidepressant abruptly after 6 months of use. He is surprised he felt completely fine after stopping. Which of the following antidepressants is least likely to cause discontinuation syndrome?", "options": [{"label": "A", "text": "Paroxetine", "correct": false}, {"label": "B", "text": "Venlafaxine", "correct": false}, {"label": "C", "text": "Fluoxetine", "correct": true}, {"label": "D", "text": "Sertraline", "correct": false}], "correct_answer": "C. Fluoxetine", "question_images": [], "explanation_images": ["https://cerebellum-web-static.s3.amazonaws.com/media/public/image_8CFbA8M.png"], "explanation": "<p><strong>Ans. C) Fluoxetine</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 6-year-old boy